TE BOEKHORST PAUL FRANCIS OLIVIER (President and CEO) purchased 9.79K shares of IMMUCELL CORP /DE/ on the open market
Open‑market purchase worth $48.6K. The strongest form of insider conviction signal.
P · 3 purchases
Filed: 12/3/2025ACC: 0001437749-25-036794
DirectorOfficer· President and CEO
Since Jan 2026
+9.79K
Net shares
Net buyer
$48.6K
Total acquired
3
Open market trades
3B · 0S
3
Total transactions
9.79K acquired
Non-Derivative Transactions3
Common Stock $0.10 par value per share
Direct
Shares
+3.71K
Price / share
$4.87
Trade value
$18.05K
% of position
New position
12/2/2025
0.00→3.71K
Common Stock $0.10 par value per share
Direct
Shares
+2.56K
Price / share
$5.00
Trade value
$12.79K
% of position
68.9%
12/3/2025
3.71K→6.26K
Common Stock $0.10 par value per share
Direct
Shares
+3.52K
Price / share
$5.04
Trade value
$17.75K
% of position
56.2%
12/3/2025
6.26K→9.79K
Total
Net shares
+9.79K
Net value
$48.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock $0.10 par value per share Direct | 12/2/2025 | P · Purchase | +3.71K | $4.87 | $18.05K | New position | 0.00 | 3.71K |
| Common Stock $0.10 par value per share Direct | 12/3/2025 | P · Purchase | +2.56K | $5.00 | $12.79K | 68.9% | 3.71K | 6.26K |
| Common Stock $0.10 par value per share Direct | 12/3/2025 | P · Purchase | +3.52K | $5.04 | $17.75K | 56.2% | 6.26K | 9.79K |
| Total | +9.79K | $48.59K | ||||||
Derivative Transactions0
No derivative transactions reported